Drug Profile
DWJ 209
Alternative Names: DWJ209Latest Information Update: 28 Feb 2019
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Lung cancer; Pancreatic cancer
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for research development in Lung-cancer in South Korea
- 28 Feb 2019 No recent reports of development identified for research development in Pancreatic-cancer in South Korea
- 21 Jan 2015 Early research in Lung cancer in South Korea (unspecified route)